These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 22868917

  • 1. MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers.
    Hung CS, Liu HH, Liu JJ, Yeh CT, Chang TC, Wu CH, Ho YS, Wei PL, Chang YJ.
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S360-8. PubMed ID: 22868917
    [Abstract] [Full Text] [Related]

  • 2. Knockdown of thrombomodulin enhances HCC cell migration through increase of ZEB1 and decrease of E-cadherin gene expression.
    Huang MT, Wei PL, Liu JJ, Liu DZ, Huey-Chun H, An J, Wu CC, Wu CH, Ho YS, Yang YY, Chang YJ.
    Ann Surg Oncol; 2010 Dec; 17(12):3379-85. PubMed ID: 20625840
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition.
    Zhou Y, Li Y, Ye J, Jiang R, Yan H, Yang X, Liu Q, Zhang J.
    Liver Int; 2013 Sep; 33(8):1271-80. PubMed ID: 23725476
    [Abstract] [Full Text] [Related]

  • 4. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q, Cai W, Zhang M, Liu Q, Liu X.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-200a inhibits epithelial-mesenchymal transition in human hepatocellular carcinoma cell line.
    Zhong C, Li MY, Chen ZY, Cheng HK, Hu ML, Ruan YL, Guo RP.
    Int J Clin Exp Pathol; 2015 Mar; 8(9):9922-31. PubMed ID: 26617701
    [Abstract] [Full Text] [Related]

  • 6. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
    Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, Chayama K.
    J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS, Wang F, Chen TC, Yeh CN, Yu MC, Jan YY, Chen MF.
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
    Zhu M, Li M, Wang T, Linghu E, Wu B.
    Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
    [Abstract] [Full Text] [Related]

  • 12. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, Zeng WX, Chen W, Yang JY.
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
    Ni F, Zhao H, Cui H, Wu Z, Chen L, Hu Z, Guo C, Liu Y, Chen Z, Wang X, Chen D, Wei H, Wang S.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):809-18. PubMed ID: 25449782
    [Abstract] [Full Text] [Related]

  • 14. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.
    Hernandez JM, Elahi A, Clark CW, Wang J, Humphries LA, Centeno B, Bloom G, Fuchs BC, Yeatman T, Shibata D.
    Ann Surg Oncol; 2013 Dec 28; 20 Suppl 3():S625-35. PubMed ID: 23864307
    [Abstract] [Full Text] [Related]

  • 15. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X.
    Sci Rep; 2016 Mar 16; 6():23091. PubMed ID: 26980408
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
    Wei W, Hu Z, Fu H, Tie Y, Zhang H, Wu Y, Zheng X.
    Oncol Rep; 2012 Aug 16; 28(2):701-6. PubMed ID: 22664953
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells.
    Liang HH, Wei PL, Hung CS, Wu CT, Wang W, Huang MT, Chang YJ.
    Tumour Biol; 2013 Oct 16; 34(5):3209-18. PubMed ID: 23760980
    [Abstract] [Full Text] [Related]

  • 18. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
    Chen W, Wu J, Shi W, Zhang G, Chen X, Ji A, Wang Z, Wu J, Jiang C.
    Cancer Sci; 2021 Jun 16; 112(6):2158-2172. PubMed ID: 33587761
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.
    Lin J, Huang S, Wu S, Ding J, Zhao Y, Liang L, Tian Q, Zha R, Zhan R, He X.
    Carcinogenesis; 2011 Nov 16; 32(11):1641-7. PubMed ID: 21890460
    [Abstract] [Full Text] [Related]

  • 20. The microRNA-200 family--a potential diagnostic marker in hepatocellular carcinoma?
    Dhayat SA, Mardin WA, Köhler G, Bahde R, Vowinkel T, Wolters H, Senninger N, Haier J, Mees ST.
    J Surg Oncol; 2014 Sep 16; 110(4):430-8. PubMed ID: 24895326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.